Skip to search formSkip to main contentSkip to account menu

CAK-ERCC2 complex

Known as: CAK-ERCC2 complex location, cyclin-dependent protein kinase activating kinase holoenzyme-ERCC2 complex, cyclin-dependent protein kinase activating kinase holoenzyme-ERCC2 complex location 
A protein complex formed by the association of the cyclin-dependent protein kinase activating kinase (CAK) holoenzyme complex with ERCC2. [PMID… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum.
2015
2015
Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer
Identification of biomarkers used for the prognostic evaluation of non-small cell lung cancer (NSCLC) patients is important. The… 
2014
2014
A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility
Published data regarding the association between the excision repair cross-complimentary group 2 (ERCC2) Asp312Asn polymorphisms… 
2013
2013
ERCC1 and ERCC2 Haplotype Modulates Induced BPDE-DNA Adducts in Primary Cultured Lymphocytes
Background Benzo[a]pyrene(B[a]P), and its ultimate metabolite Benzo[a]pyrene 7,8-diol 9,10-epoxide (BPDE), are classic DNA… 
2013
2013
A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population.
Endogenous and exogenous factors can induce DNA damage, leading to increased risk of cancer. Nucleotide excision repair (NER) is… 
2013
2013
Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients.
The purpose of the study was to investigate the possible association between ERCC2 rs28365048, ERCC5 rs17655, XRCC3 rs861539 and… 
2011
2011
Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer
PurposeInter-individual variations in treatment efficacy may be influenced by polymorphisms in DNA repair genes. We investigated… 
2011
2011
Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) Polymorphism on Outcome of Advanced-Stage Squamous Cell Carcinoma of the Head and Neck Are Treatment Dependent
Background: Germline variation in DNA damage response may explain variable treatment outcomes in squamous cell carcinoma of the… 
2011
2011
ERCC2 Lys751Gln and Asp312Asn polymorphisms and gastric cancer risk: a meta-analysis
PurposeStudies investigating the association between excision repair cross-complimentary group 2 (ERCC2) polymorphisms and… 
2010
2010
The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects
To date, many publications discussed the correlation between ERCC2 Asp312Asn polymorphism and breast cancer risk. However, the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)